T-Cypher Bio Holdings
Latest round
- Seed
Last raised
- Oct 2021
Total raised
- $4M
Investors
- 4
About T-Cypher Bio Holdings
Based in Oxfordshire, UK, and founded in 2020, T-Cypher Bio Holdings Limited operates as a healthcare-based company providing treatment of autoimmune, inflammatory, and infectious diseases through TCR-based therapeutics. As of 2023, Thomas Lars Andresen operates as a Chief Executive Officer of T-Cypher Bio Holdings Limited. T-Cypher Bio Holdings Limited developed therapeutics, diagnostics, and technologies for supporting and improving the medical industries. The company offers T-cell receptor (TCR) therapies for the treatment of solid tumors, autoimmune, inflammatory, and infectious diseases. In addition, the firm’s technology provides identifies T-cell clones directly from disease tissues using target screening libraries.
Who invested in T-Cypher Bio Holdings
4 investors across 1 round
See all investors in T-Cypher Bio Holdings
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 22, 2021
Amount
$4M
Investors
Questions about T-Cypher Bio Holdings
Who invested in T-Cypher Bio Holdings?
T-Cypher Bio Holdings has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has T-Cypher Bio Holdings raised?
T-Cypher Bio Holdings has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did T-Cypher Bio Holdings last raise money?
T-Cypher Bio Holdings's most recent round on record is a Seed, in Oct 2021.
What does T-Cypher Bio Holdings do?
Based in Oxfordshire, UK, and founded in 2020, T-Cypher Bio Holdings Limited operates as a healthcare-based company providing treatment of autoimmune, inflammatory, and infectious diseases through TCR-based therapeutics.
Where is T-Cypher Bio Holdings headquartered?
T-Cypher Bio Holdings is headquartered in Oxford, UK.
Which VCs invest in companies like T-Cypher Bio Holdings?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at T-Cypher Bio Holdings's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like T-Cypher Bio Holdings? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.